Amedeo Smart

Free Medical Literature Service


 

Amedeo

Liver Diseases

  Free Subscription

19.09.2022

2 Am J Gastroenterol
1 BMC Gastroenterol
2 Br J Surg
3 Eur Radiol
1 Gastrointest Endosc
4 Hepatology
1 J Comput Assist Tomogr
4 J Gastroenterol Hepatol
2 J Hepatol
1 Lancet
5 Minerva Gastroenterol (Torino)
4 PLoS One



    Am J Gastroenterol

  1. ZACCHERINI G, Baldassarre M, Tufoni M, Nardelli S, et al
    Correction and prevention of hyponatremia in patients with cirrhosis and ascites - Post hoc analysis of the ANSWER study database.
    Am J Gastroenterol. 2022 Sep 6. pii: 00000434-990000000-00502.
    >> Share

  2. TANDON P, Pidborochynski T, Abraldes JG, Carbonneau M, et al
    The assessment of driving fitness using an on-road driving evaluation in patients with cirrhosis.
    Am J Gastroenterol. 2022 Aug 12. pii: 00000434-990000000-00462.
    >> Share


    BMC Gastroenterol

  3. ZHENG L, Huang Z, Li X, He M, et al
    Construction and validation of a predictive model for hepatocellular carcinoma based on serum markers.
    BMC Gastroenterol. 2022;22:418.
    >> Share


    Br J Surg

  4. WONG D, Ng ZQ, Weber D
    Author response to: Comment on: Unfamiliar liver lesions.
    Br J Surg. 2022;109:e115.
    >> Share

  5. DIAO X, Wei L, Zhou H
    Comment on: Unfamiliar liver lesions.
    Br J Surg. 2022;109:e114.
    >> Share


    Eur Radiol

  6. HUANG JX, Shi CG, Xu YF, Fu J, et al
    The benefit of contrast-enhanced ultrasound in biopsies for focal liver lesions: a retrospective study of 820 cases.
    Eur Radiol. 2022 Jul 26. pii: 10.1007/s00330-022-08988.
    >> Share

  7. WANG MQ, Duan F, Guan Y, Yuan B, et al
    Long-term outcomes of transarterial embolization with lipiodol-bleomycin emulsion plus polyvinyl alcohol particles versus the particles alone for large symptomatic focal nodular hyperplasia: a propensity score-matched analysis.
    Eur Radiol. 2022 Jun 28. pii: 10.1007/s00330-022-08972.
    >> Share

  8. LIU B, Zeng Q, Huang J, Zhang J, et al
    IVIM using convolutional neural networks predicts microvascular invasion in HCC.
    Eur Radiol. 2022 Jun 17. pii: 10.1007/s00330-022-08927.
    >> Share


    Gastrointest Endosc

  9. TAKENAKA M, Omoto S, Fukunaga T, Kudo M, et al
    The usefulness of texture and color-enhanced imaging for balloon endoscopy-assisted ERCP for hepatic-jejunal anastomotic stenosis.
    Gastrointest Endosc. 2022 Sep 6. pii: S0016-5107(22)01945.
    >> Share


    Hepatology

  10. DELLINGER RW, Holmes HE, Hu-Seliger T, Butt RW, et al
    NRPT reduces markers of hepatic inflammation in non-alcoholic fatty liver disease: a double-blind, placebo-controlled clinical trial.
    Hepatology. 2022 Sep 9. doi: 10.1002/hep.32778.
    >> Share

  11. LEE YT, Fujiwara N, Yang JD, Hoshida Y, et al
    Risk stratification and early detection biomarkers for precision hepatocellular carcinoma screening.
    Hepatology. 2022 Sep 9. doi: 10.1002/hep.32779.
    >> Share

  12. VIZZUTTI F, Celsa C, Battaglia S, Miraglia R, et al
    Reply to the Letter to the Editor: "Reflection on the unsatisfactory model predicting mortality after TIPS in cirrhotic patients".
    Hepatology. 2022 Sep 13. doi: 10.1002/hep.32784.
    >> Share

  13. LESLIE J, Hunter JE, Collins A, Rushton A, et al
    c-Rel dependant Chk2 signalling regulates the DNA damage response limiting hepatocarcinogenesis.
    Hepatology. 2022 Sep 11. doi: 10.1002/hep.32781.
    >> Share


    J Comput Assist Tomogr

  14. KIRSHENBOIM Z, Marom EM, Mayer A, Green M, et al
    Liver Attenuation Assessment in Reduced Radiation Chest Computed Tomography.
    J Comput Assist Tomogr. 2022 Jun 4. pii: 00004728-990000000-00046.
    >> Share


    J Gastroenterol Hepatol

  15. JEE JJ, Lim J, Park S, Koh H, et al
    Gut microbial community differentially characterizes patients with nonalcoholic fatty liver disease.
    J Gastroenterol Hepatol. 2022;37:1822-1832.
    >> Share

  16. LIM SZ, Chuah KH, Rajaram RB, Stanley K, et al
    Epidemiological trends of gastrointestinal and liver diseases in Malaysia: A single-center observational study.
    J Gastroenterol Hepatol. 2022;37:1732-1740.
    >> Share

  17. INADA K, Tamaki N, Kurosaki M, Kirino S, et al
    Validation of magnetic resonance elastography plus fibrosis-4 for significant fibrosis in nonalcoholic fatty liver disease.
    J Gastroenterol Hepatol. 2022;37:1726-1731.
    >> Share

  18. YANG W, Yusufu Y, Wang C
    Gastrointestinal: A rare case of upper gastrointestinal bleeding: Splenosis mimicking gastric varices.
    J Gastroenterol Hepatol. 2022 Mar 1. doi: 10.1111/jgh.15795.
    >> Share


    J Hepatol

  19. PARIKH ND, Tayob N, Singal AG
    Blood-based biomarkers for hepatocellular carcinoma screening: Approaching the end of the ultrasound era?
    J Hepatol. 2022 Sep 8. pii: S0168-8278(22)03067.
    >> Share

  20. KAZANKOV K, Novelli S, Chatterjee DA, Phillips A, et al
    Evaluation of CirrhoCare(R) - A digital-health solution for home management of patients with cirrhosis.
    J Hepatol. 2022 Sep 7. pii: S0168-8278(22)03066.
    >> Share


    Lancet

  21. VOGEL A, Meyer T, Sapisochin G, Salem R, et al
    Hepatocellular carcinoma.
    Lancet. 2022 Sep 6. pii: S0140-6736(22)01200.
    >> Share


    Minerva Gastroenterol (Torino)

  22. CATANZARO R, Selvaggio F, Sciuto M, Zanoli L, et al
    Triglycerides to high-density lipoprotein cholesterol ratio for diagnosing nonalcoholic fatty liver disease.
    Minerva Gastroenterol (Torino). 2022;68:261-268.
    >> Share

  23. YU Y, Zhang L, Xu J
    LncRNA BANCR promotes proliferation of hepatocellular carcinoma Huh-7 cells by activating Wnt/beta-catenin signaling pathway.
    Minerva Gastroenterol (Torino). 2022;68:341-343.
    >> Share

  24. WANG Z, Wang W, Zhou L, Ren L, et al
    MiR-34a targets SNAI1 and is essential for 5-hydroxytryptamine induced epithelial mesenchymal transition in liver cancer.
    Minerva Gastroenterol (Torino). 2022;68:363-365.
    >> Share

  25. TESTINO G, Pellicano R
    SARS-CoV-2 vaccination in alcohol related liver disease.
    Minerva Gastroenterol (Torino). 2022;68:336-337.
    >> Share

  26. TESTINO G, Pellicano R
    SARS-CoV-2, autoimmunity and liver disease.
    Minerva Gastroenterol (Torino). 2022;68:338-339.
    >> Share


    PLoS One

  27. ASATURYAN HA, Basty N, Thanaj M, Whitcher B, et al
    Improving the accuracy of fatty liver index to reflect liver fat content with predictive regression modelling.
    PLoS One. 2022;17:e0273171.
    >> Share

  28. HENDRYX M, Dong Y, Ndeke JM, Luo J, et al
    Sodium-glucose cotransporter 2 (SGLT2) inhibitor initiation and hepatocellular carcinoma prognosis.
    PLoS One. 2022;17:e0274519.
    >> Share

  29. LASCANO J, Oshins R, Eagan C, Wadood Z, et al
    Correlation of alpha-1 antitrypsin levels and exosome associated neutrophil elastase endothelial injury in subjects with SARS-CoV2 infection.
    PLoS One. 2022;17:e0274427.
    >> Share

  30. WEIHER M, Richtering FG, Dorffel Y, Muller HP, et al
    Simplification of 2D shear wave elastography by enlarged SWE box and multiple regions of interest in one acquisition.
    PLoS One. 2022;17:e0273769.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016